‘Pharma resistance’ to battle superbugs

  24 September 2020

A group of pharmaceutical ­giants, biotech companies, industry peak bodies and the CSIRO have banded together to form an alliance to combat the “market failure” that inhibits the development of novel antibiotics to fight superbugs.

The Australian Antimicrobial Resistance Network — known as AAMRNet — will work to secure reforms aimed at incentivising antibiotic research and development in the face of an escalating crisis in which modern medicine is running out of ­options to treat drug-resistant infections.

Further reading: The Australian
Author(s): Natasha Robinson
Healthy Patients   Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed